Gabapentin to Reduce Alcohol and Improve Viral Load Suppression — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Gabapentin to Reduce Alcohol and Improve Viral Load Suppression — Stella

Recruiting

Back to HIV trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Uganda

Mbarara Regional Referral Hospital (MRRH): Immune Suppression Syndrome HIV, Mbarara

Key details

Phase

Safety & dosing

Sponsor

Boston Medical Center

Collaborators

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Enrollment target

~220 participants

Started

November 2023

Primary completion

August 2026

Age range

18 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov